G1/S phase progression is regulated by PLK1 degradation through the CDK1/βTrCP axis

被引:20
作者
Giraldez, Servando [1 ]
Galindo-Moreno, Maria [1 ]
Cristina Limon-Mortes, M. [1 ]
Cristina Rivas, A. [1 ]
Herrero-Ruiz, Joaquin [1 ]
Mora-Santos, Mar [1 ]
Saez, Carmen [2 ,3 ]
Japon, Miguel A. [2 ,3 ]
Tortolero, Maria [1 ]
Romero, Francisco [1 ]
机构
[1] Univ Seville, Fac Biol, Dept Microbiol, Seville, Spain
[2] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBIS, Seville, Spain
[3] Hosp Univ Virgen del Rocio, Dept Anat Patol, Seville, Spain
关键词
cell cycle; HSP90; protein degradation; ubiquitin ligase; POLO-LIKE KINASE-1; CELL-CYCLE PROGRESSION; SCF-BETA-TRCP; UBIQUITIN LIGASE; MAMMALIAN-CELLS; GENE-EXPRESSION; PROTEIN-KINASE; CHECKPOINT; CANCER; HSP90;
D O I
10.1096/fj.201601108R
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Polo-like kinase 1 (PLK1) is a serine/threonine kinase involved in several stages of the cell cycle, including the entry and exit from mitosis, and cytokinesis. Furthermore, it has an essential role in the regulation of DNA replication. Together with cyclin A, PLK1 also promotes CDH1 phosphorylation to trigger its ubiquitination and degradation, allowing cell cycle progression. The PLK1 levels in different type of tumors are very high compared to normal tissues, which is consistent with its role in promoting proliferation. Therefore, several PLK1 inhibitors have been developed and tested for the treatment of cancer. Here, we further analyzed PLK1 degradation and found that cytoplasmic PLK1 is ubiquitinated and subsequently degraded by the SCF1mcP/proteasome. This procedure is triggered when heat shock protein (HSP) 90 is inhibited with geldanamycin, which results in misfolding of PLK1. We also identified CDK1 as the major kinase involved in this degradation. Our work shows for the first time that HSP90 inhibition arrests cell cycle progression at the Gi/S transition. This novel mechanism inhibits CDH1 degradation through CDK1-dependent PLK1 destruction by the SCF beta TrcP/proteasome. In these conditions, CDH1 substrates do not accumulate and cell cycle arrests, providing a novel pathway for regulation of the cell cycle at the G1-to-S boundary. Giraldez, S., Galindo-Moreno, M., Limon-Mortes, M. C., Rivas, A. C., Herrero-Ruiz, J., Mora Santos, M., Saez, C., Japon, M. A., Tortolero, M., Romero, F. Gi/S phase progression is regulated by PLK1 degradation through the CDK1/beta TrCP axis.
引用
收藏
页码:2925 / 2936
页数:12
相关论文
共 56 条
[1]   beta-catenin is a target for the ubiquitin-proteasome pathway [J].
Aberle, H ;
Bauer, A ;
Stappert, J ;
Kispert, A ;
Kemler, R .
EMBO JOURNAL, 1997, 16 (13) :3797-3804
[2]   Polo-like kinases and the orchestration of cell division [J].
Barr, FA ;
Silljé, HHW ;
Nigg, EA .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2004, 5 (06) :429-440
[3]   The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint [J].
Bassermann, Florian ;
Frescas, David ;
Guardavaccaro, Daniele ;
Busino, Luca ;
Peschiaroli, Angelo ;
Pagano, Michele .
CELL, 2008, 134 (02) :256-267
[4]   Switching Polo-like kinase-1 on and off in time and space [J].
Bruinsma, Wytse ;
Raaijmakers, Jonne A. ;
Medema, Rene H. .
TRENDS IN BIOCHEMICAL SCIENCES, 2012, 37 (12) :534-542
[5]   Maximizing the Therapeutic Potential of HSP90 Inhibitors [J].
Butler, Lisa M. ;
Ferraldeschi, Roberta ;
Armstrong, Heather K. ;
Centenera, Margaret M. ;
Workman, Paul .
MOLECULAR CANCER RESEARCH, 2015, 13 (11) :1445-1451
[6]   Heat shock protein 90 regulates the metaphase-anaphase transition in a polo-like kinase-dependent manner [J].
de Cárcer, G .
CANCER RESEARCH, 2004, 64 (15) :5106-5112
[7]   Requirement of Hsp90 for centrosomal function reflects its regulation of Polo kinase stability [J].
de Cárcer, G ;
Avides, MD ;
Lallena, MJ ;
Glover, DM ;
González, C .
EMBO JOURNAL, 2001, 20 (11) :2878-2884
[8]   Cyclins and cdks in development and cancer: a perspective [J].
Deshpande, A ;
Sicinski, P ;
Hinds, PW .
ONCOGENE, 2005, 24 (17) :2909-2915
[9]   The ubiquitin ligase APCCdh1 is required to maintain genome integrity in primary human cells [J].
Engelbert, D. ;
Schnerch, D. ;
Baumgarten, A. ;
Waesch, R. .
ONCOGENE, 2008, 27 (07) :907-917
[10]   A NOVEL GENETIC SYSTEM TO DETECT PROTEIN PROTEIN INTERACTIONS [J].
FIELDS, S ;
SONG, OK .
NATURE, 1989, 340 (6230) :245-246